SeaStar Medical Holding (ICUCW) Return on Sales (2023 - 2025)
Historic Return on Sales for SeaStar Medical Holding (ICUCW) over the last 3 years, with Q3 2025 value amounting to 18.97%.
- SeaStar Medical Holding's Return on Sales rose 468800.0% to 18.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 15.51%, marking a year-over-year increase of 4237200.0%. This contributed to the annual value of 183.93% for FY2024, which is N/A changed from last year.
- As of Q3 2025, SeaStar Medical Holding's Return on Sales stood at 18.97%, which was up 468800.0% from 5.92% recorded in Q2 2025.
- SeaStar Medical Holding's 5-year Return on Sales high stood at 141.48% for Q1 2024, and its period low was 65.96% during Q4 2024.
- Moreover, its 3-year median value for Return on Sales was 5.92% (2025), whereas its average is 4.34%.
- Its Return on Sales has fluctuated over the past 5 years, first surged by 1250900bps in 2024, then tumbled by -1543500bps in 2025.
- Quarter analysis of 3 years shows SeaStar Medical Holding's Return on Sales stood at 39.87% in 2023, then crashed by -265bps to 65.96% in 2024, then soared by 71bps to 18.97% in 2025.
- Its Return on Sales was 18.97% in Q3 2025, compared to 5.92% in Q2 2025 and 12.87% in Q1 2025.